Sumit Dutta of OptumRx Discusses COVID Vaccines, How PBM was Affected by the Pandemic
January 9th 2021There currently aren't enough vaccines in the United States, and between the Pfizer and Moderna vaccines, the two are very important to get their hands on, Sumit Dutta, MD, MBA, of OptumRx, says in this part one of a two-part video interview series.
Watch
Prescription Digital Therapeutics: Coverage and Reimbursement
January 6th 2021Steven Peskin, MD, MBA, FACP, shares perspective on factors that need to be considered by payers when making decisions about how to cover and reimburse for prescription digital therapeutics used to manage behavior-driven conditions.
Watch
Prescription Digital Therapeutics: Clinical Outcomes
January 6th 2021Current experiences noted by various stakeholders in healthcare regarding the impact of prescription digital therapeutics in clinical practice as tools to help manage patients with behavior-driven conditions, and current limitations that need to be addressed to increase their uptake.
Watch
Prescription Digital Therapeutics in Behavior-Driven Conditions EP2
January 6th 2021Clinicians, a pharmacist, and a payer discuss their current experience with prescription digital therapeutics for behavior-driven conditions and share considerations for expanding on their use in clinical practice.
Watch
The Future of BCBS Minnesota with MLRs, Investing in Telehealth Models
January 2nd 2021In this second of a three-part video series, Craig Samitt, CEO and president of Blue Cross Blue Shield of Minnesota talks with MHE about healthcare utilization, MLR rates and investing in telehealth models for the better care of its members.
Watch
A Labeling Indication of SPMS Can Treat More Patients
December 16th 2020Fred Lublin, MD, says a new labeling indication of Secondary Progressive Multiple Sclerosis broadens whom you can treat. He adds this will be very helpful to patients because it will treat groups that are progressing slowly without agents of activity.
Watch
Accumulator, Maximizer Regulation Picks up at the State Level
December 12th 2020The five states have moved to prohibit accumulators and maximizers as the federal government takes a hands-off approach, according to John “Jack” S. Linehan, a lawyer at Epstein Becker Green, who is featured in this second part of a two-part video series.
Watch
Biomarkers Used to Detect Secondary Progressive MS Needs Improvement for the Care of Patients
December 11th 2020Thomas P. Leist, MD, PhD, says doctors working with patients diagnosed with SPMS don't necessarily have prognostic biomarkers to detect SPMS. The best prognostic biomarkers they have currently are MRI and potentially neurofilament light. He adds their techniques need to improve in order to harness the full benefit of potentially individualizing care to the most optimal fashion in a given patient.
Watch